Trial Profile
DAS Evaluation of RA Activity in Patients Treated With Tocilizumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.